SPONSOR
Mao Jianhua
Total Trials
2
Recruiting
2
Phases
Phase 3, Phase 2
Conditions studied: Nephrotic Syndrome in Children
Mao Jianhua is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Nephrotic Syndrome in Children.
The trial portfolio spans Phase 3, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Mao Jianhua
How many clinical trials has Mao Jianhua sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Mao Jianhua, of which 2 are actively recruiting participants. These trials cover conditions including Nephrotic Syndrome in Children. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Mao Jianhua research focus on?
Mao Jianhua clinical trials span Nephrotic Syndrome in Children. The research pipeline includes Phase 3, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Mao Jianhua clinical trial?
To participate in a Mao Jianhua trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Mao Jianhua trials with current recruitment status updated daily.
Clinical Trials by Mao Jianhua
NCT06079788 Phase 3
Recruiting
Study of Adrenocorticotropic Hormone on Children With Frequent Relapse or Steroid-dependent Nephrotic Syndrome: a Prospective, Multicenter, Randomized，Open-label Clinical Trial.
Nephrotic Syndrome in Children
NCT07087314 Phase 2
Recruiting
A Study of Anti-CD38 Monoclonal Antibody (SG301) Subcutaneous Injection in Children With Nephrotic Syndrome With Frequent Relapses or Steroid Dependence
Nephrotic Syndrome in Children
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology